GERMLINE BRCA1 GENE MUTATION
Clinical trials for GERMLINE BRCA1 GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new GERMLINE BRCA1 GENE MUTATION trials appear
Sign up with your email to follow new studies for GERMLINE BRCA1 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hard-to-treat breast cancer: drug combo targets resistance
Disease control Recruiting nowThis study tests whether adding another drug (cediranib or AZD6738) to the PARP inhibitor olaparib can shrink tumors or slow cancer growth in people with advanced BRCA-mutated breast cancer that has stopped responding to PARP inhibitors. About 60 adults with HER2-negative, BRCA-p…
Matched conditions: GERMLINE BRCA1 GENE MUTATION
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
App aims to slash cancer risk by cutting junk food
Prevention Recruiting nowThis study tests whether a digital app (Open Food Facts) plus nutrition education can help 170 people at high risk for breast, pancreas, colon cancer, or with Lynch syndrome or BRCA mutations improve their diet quality. Participants will use the app to reduce ultra-processed food…
Matched conditions: GERMLINE BRCA1 GENE MUTATION
Phase: NA • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Prevention
Last updated May 14, 2026 12:05 UTC